What we Offer
Our goal is to create new business in the life science space. We do this by exploring and testing new game-changing business models in collaboration with partners. We are continuously expanding our network of partners and key opinion leaders in our innovation target areas. We possess comprehensive expertise in business, product management and development, marketing, IP, finance and investment, and life science applications, such as molecular biology.
Investment scope and typical terms
Typical investment terms:
- Market segments: Life science tools, research-use-only and clinical diagnostics
- Regional focus: North America and Europe
- Investment stages: (Late) seed, (pre-)series A and series B
- Minority investments: Up to 20%, as lead or follower, co-investments with other (financial) VCs possible, seeking board seat
- Investment size: Up to 10 Mio. € per project and round
Our Investments
Molecular biology
✔ Liquid biopsy
✔ Omics sample prep
✔ Workflow solutions in early cancer detection and monitoring
Digital solutions
✔ Data-driven business models and AI/self learning systems
✔ Novel approaches to enhance lab productivity and quality of results
✔ Continuous lab process improvement / benchmarking
Cell biology
✔ Cell culture and single cell applications
✔ Novel cellular models of organs (i.e. organoids)
